Dr. Catherine A. Biren, MD

Dr. Biren practices at Orchard Creek Surgery Center - Mountain View in Mountain View, California.

Dr. Biren's NPI, 1124021035, was assigned on May 24, 2005. Dr. Biren graduated from Feinberg School of Medicine in 1980. Dr. Biren's California license number on file is G48190.

Dr. Biren's primary practice is Orchard Creek Surgery Center - Mountain View, at 525 South Drive, Suite 115, Mountain View, CA 94040. The practice phone is (650) 969-5600.

Dr. Biren's primary practice is Orchard Creek Surgery Center - Mountain View in Mountain View, California. Dr. Biren is also affiliated with Community Hospital of the Monterey Peninsula. The medical group on file is Schweiger Dermatology Group, San Pedro. Dmand AI also links Dr. Biren to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Biren practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Biren's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Biren is board certified in dermatology by the American Board of Dermatology. Dr. Biren has a license on file in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, minor injury to a limb, rash and scalp rash among the conditions Dr. Biren treats.

CMS data shows 1,031 Medicare services from Dr. Biren across 10 procedure codes in 2024, for 229 Medicare patients. Medicare paid $41,110 for them. Every service was in an office.

CMS counts 229 Medicare patients who saw Dr. Biren in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 11% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Biren's median patient age at 69, with 68% women.

In 2024, Dr. Biren wrote 270 Medicare Part D claims for 127 patients. 98% of them were for generic drugs. CMS names the drug for 197 of them, across 4 drugs with 11 or more claims each, at $3,802 in total drug cost. In 2023, CMS named 252 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Biren for performance year 2024, reported as part of a group. Dr. Biren accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 374 procedures of removal of skin lesions by Dr. Biren, more than 84% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Biren. The most frequent topics are Cyclosporins, Graft Survival and Rats, Inbred Lew. Dr. Biren has published most often in J Invest Dermatol. Dr. Biren's most frequent co-author is Ronald Jeffrey Barr, MD.

CMS Open Payments shows 197 general payments to Dr. Biren from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,006.

Dmand AI lists 2 awards for Dr. Biren.

Dr. Biren graduated from Feinberg School of Medicine in 1980. Dr. Biren is a member of AAD and ASDS.

Dr. Biren is in network with 7 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.